In its first three months, more than 130 patients have died through a voluntary assisted dying (VAD) programme in NSW, Australia.

Since VAD was legalised in November 2023, 517 patients requested access, and 131 completed the process.

The NSW Voluntary Assisted Dying Board's interim report detailed that 408 patients underwent a first assessment between November 2023 and February 2024. Of these, 321 completed the second step of a consulting assessment, and 248 applied for substance authorisation.

Of those who completed the process and ended their lives, 30% self-administered the lethal substance.

Prof Jenni Millbank, the board chair, noted many patients who receive substance authority choose not to use it, finding comfort in having the option.

Of the 246 successful authorisations, 115 patients did not use it, and 29 died from other causes during the reporting period.

This raises questions over who might access the substance outside of the intended user if the substance goes unused.

The board meets twice weekly and sometimes more frequently for urgent cases to ensure eligible patients can access VAD promptly.

The NSW government passed VAD legislation in May 2022, limiting access to terminally ill patients expected to die within six or 12 months if suffering from a neurodegenerative condition.

The process requires assessment by two medical practitioners and offers patients the choice to self-administer the medication or have it administered by a doctor.

Closer to home, the debate about physician assisted suicide has been reignited with several organisations campaigning across the UK.

In Scotland, MSPs are considering legislation to allow doctors to administer lethal drugs to people with terminal conditions.